These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 1505460)

  • 1. Constitutive expression of osteoclast-stimulating activity by normal clonal osteoblast-like cells: effects of parathyroid hormone and 1,25-dihydroxyvitamin D3.
    Collin P; Guenther HL; Fleisch H
    Endocrinology; 1992 Sep; 131(3):1181-7. PubMed ID: 1505460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cloning of an osteoblastic cell line involved in the formation of osteoclast-like cells.
    Yamashita T; Asano K; Takahashi N; Akatsu T; Udagawa N; Sasaki T; Martin TJ; Suda T
    J Cell Physiol; 1990 Dec; 145(3):587-95. PubMed ID: 1703173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of osteocalcin production and bone resorption by 1,25-dihydroxyvitamin D3 in mouse long bones: interaction with the bone-derived growth factors TGF-beta and IGF-I.
    Staal A; Geertsma-Kleinekoort WM; Van Den Bemd GJ; Buurman CJ; Birkenhäger JC; Pols HA; Van Leeuwen JP
    J Bone Miner Res; 1998 Jan; 13(1):36-43. PubMed ID: 9443788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of 24R,25-dihydroxyvitamin D3 on the formation and function of osteoclastic cells.
    Yamato H; Okazaki R; Ishii T; Ogata E; Sato T; Kumegawa M; Akaogi K; Taniguchi N; Matsumoto T
    Calcif Tissue Int; 1993 Mar; 52(3):255-60. PubMed ID: 8481842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of osteoclast characteristics in cultured avian blood monocytes; modulation by osteoblasts and 1,25-(OH)2 vitamin D3.
    van't Hof RJ; Tuinenburg-Bol Raap AC; Nijweide PJ
    Int J Exp Pathol; 1995 Jun; 76(3):205-14. PubMed ID: 7547432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of dual signal transduction systems in the stimulation of osteoclast-like cell formation by parathyroid hormone and parathyroid hormone-related peptide.
    Kaji H; Sugimoto T; Kanatani M; Fukase M; Chihara K
    Biochem Biophys Res Commun; 1993 Jul; 194(1):157-62. PubMed ID: 8392835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heat-treated osteoblastic cell (ROS17/2.8)-conditioned medium induces the formation of osteoclast-like cells.
    Kukita A; Kukita T; Hata K; Kurisu K; Kohashi O
    Bone Miner; 1993 Nov; 23(2):113-27. PubMed ID: 8305877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 1,25-Dihydroxyvitamin D3 stimulates rat osteoblastic cells to release a soluble factor that increases osteoclastic bone resorption.
    McSheehy PM; Chambers TJ
    J Clin Invest; 1987 Aug; 80(2):425-9. PubMed ID: 3611354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential regulation of insulin-like growth factor-I (IGF-I) and IGF-II release from cultured neonatal mouse calvaria by parathyroid hormone, transforming growth factor-beta, and 1,25-dihydroxyvitamin D3.
    Linkhart TA; Keffer MJ
    Endocrinology; 1991 Mar; 128(3):1511-8. PubMed ID: 1999170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction between effects of parathyroid hormone and bisphosphonate on regulation of osteoclast activity by the osteoblast-like cell line UMR-106.
    Yu X; Schøller J; Foged NT
    Bone; 1996 Oct; 19(4):339-45. PubMed ID: 8894139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carboxyl-terminal parathyroid hormone fragments stimulate osteoclast-like cell formation and osteoclastic activity.
    Kaji H; Sugimoto T; Kanatani M; Miyauchi A; Kimura T; Sakakibara S; Fukase M; Chihara K
    Endocrinology; 1994 Apr; 134(4):1897-904. PubMed ID: 8137758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bisphosphonates induce osteoblasts to secrete an inhibitor of osteoclast-mediated resorption.
    Vitté C; Fleisch H; Guenther HL
    Endocrinology; 1996 Jun; 137(6):2324-33. PubMed ID: 8641182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stimulatory effect of bone morphogenetic protein-2 on osteoclast-like cell formation and bone-resorbing activity.
    Kanatani M; Sugimoto T; Kaji H; Kobayashi T; Nishiyama K; Fukase M; Kumegawa M; Chihara K
    J Bone Miner Res; 1995 Nov; 10(11):1681-90. PubMed ID: 8592944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of high phosphate concentration on osteoclast differentiation as well as bone-resorbing activity.
    Kanatani M; Sugimoto T; Kano J; Kanzawa M; Chihara K
    J Cell Physiol; 2003 Jul; 196(1):180-9. PubMed ID: 12767054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osteoclast-like cell formation and its regulation by osteotropic hormones in mouse bone marrow cultures.
    Takahashi N; Yamana H; Yoshiki S; Roodman GD; Mundy GR; Jones SJ; Boyde A; Suda T
    Endocrinology; 1988 Apr; 122(4):1373-82. PubMed ID: 3345718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteoblastic cells mediate osteoclastic responsiveness to parathyroid hormone.
    McSheehy PM; Chambers TJ
    Endocrinology; 1986 Feb; 118(2):824-8. PubMed ID: 3455914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteoblast-like cells in the presence of parathyroid hormone release soluble factor that stimulates osteoclastic bone resorption.
    McSheehy PM; Chambers TJ
    Endocrinology; 1986 Oct; 119(4):1654-9. PubMed ID: 3463505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of protease-activated receptor-2 leads to inhibition of osteoclast differentiation.
    Smith R; Ransjö M; Tatarczuch L; Song SJ; Pagel C; Morrison JR; Pike RN; Mackie EJ
    J Bone Miner Res; 2004 Mar; 19(3):507-16. PubMed ID: 15040840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic effects of parathyroid hormone and 1,25-dihydroxyvitamin D3 on proliferation and vitamin D receptor expression of rat growth cartilage cells.
    Klaus G; von Eichel B; May T; Hügel U; Mayer H; Ritz E; Mehls O
    Endocrinology; 1994 Oct; 135(4):1307-15. PubMed ID: 7523093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microrough implant surface topographies increase osteogenesis by reducing osteoclast formation and activity.
    Lossdörfer S; Schwartz Z; Wang L; Lohmann CH; Turner JD; Wieland M; Cochran DL; Boyan BD
    J Biomed Mater Res A; 2004 Sep; 70(3):361-9. PubMed ID: 15293309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.